Ledger.Open graph →
SEC Form D · Amendment · filed April 22, 2019

Noveome Biotherapeutics, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PITTSBURGH, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven Shores · Atlanta, GADirectorCharles Mann · Fort Wayne, INExec · DirectorDonald Wagner · Pittsburgh, PADirectorChristopher T. Pierson · Lake Mary, FLDirectorKeith K. Caldwell · Bethlehem, PADirectorTerence Golden · Pittsburgh, PADirectorJohn Mcarthur · Pittsburgh, PADirectorPatrick Welch · Pittsburgh, PADirectorJeffrey D. Martin · Bethlehem, PADirectorRobert Langer · Pittsburgh, PADirectorLeland K. Carter · Bethlehem, PADirectorMatthew Buck · Hong Kong, Hong KongDirectorMichael Huber · New York, NYDirectorRichard K. Thompson · Bethlehem, PAExec · DirectorAndrew J. Spokes · San Francisco, CADirectorBruce C. Sanders · Atlanta, GADirectorBradley Fishman · New York, NYDirectorWilliam Golden · Pittsburgh, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗